Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2026-06-05 17:57:16 ET · period of report 2026-06-03 · accession 0001628280-26-041332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-05 17:57 | 2026-06-03 | PCRX | RIKER LAUREN | SVP, Fin | F - Tax | $22.32 | -3,187 | 68.4K | -4% | -$71.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-03 | F | D | 3,187 | $22.32 | 68,399.24 | D | — | — | (F1) Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. |